Literature DB >> 31372271

Changing trends in aortic valve procedures over the past ten years-from mechanical prosthesis via stented bioprosthesis to TAVI procedures-analysis of 50,846 aortic valve cases based on a Polish National Cardiac Surgery Database.

Krzysztof Bartus1, Jerzy Sadowski1, Radoslaw Litwinowicz1, Grzegorz Filip1, Marek Jasinski2, Marek Deja3, Mariusz Kusmierczyk4, Szymon Pawlak5,6, Marek Jemielity7, Dariusz Jagielak8, Piotr Hendzel9, Piotr Suwalski10,11, Zdzisław Tobota12, Bohdan Maruszewski12, Boguslaw Kapelak1.   

Abstract

BACKGROUND: Aortic valve replacement (AVR) is one of the most common surgeries performed in cardiac surgery operating rooms. We present actual, real life trends from the last 10 years for AVR interventions based on a multicentre National Registry of Cardiac Surgery Database.
METHODS: The study population consisted of all 50,846 consecutive adult patients who underwent AVR between January 2006 and August 2016 in all cardiac surgery units in Poland. The main outcome measures were changes in the number of valves, characteristics of valves, operative details, and in-hospital mortality. Analysis consisted of all aortic valve (AV) procedures, including isolated AV surgery, combination procedures and patients who had a prior valve operation.
RESULTS: In last 10 years, the number of procedures increased by 46%. Isolated surgical AVR was performed in 61.2%, AVR + coronary artery bypass grafting (CABG) in 23.9%, AVR + mitral valve replacement (MVR) in 7%, and transcatheter aortic valve implantation (TAVI) in 2.3% of patients. The mean patient age increased significantly from 61.4 years in 2006 to 66.1 years in 2016. Aortic stenosis was diagnosed in 73.4%, severe aortic insufficiency in 15.8% of cases. The most common valve pathology was calcification. Congenital valve dysfunction was diagnosed in 3.7% of cases. There was a 33.7% increase of bioprosthesis, and the most common implanted bioprosthesis was the Hancock II. The most common implanted mechanical prosthesis was the St. Jude Medical Mechanical Valve. In-hospital mortality decreased significantly over the 10-year period in all AV procedures from 10.9% in 2006 to 8.3% in 2016. Mean in-hospital mortality was: 4.0% in isolated surgical AVR, 5.4% in TAVI, 6.8% in AVR + CABG, 9.8% in AVR + MVR, 17.2% in AVR + MVR + CABG.
CONCLUSIONS: In the last ten years, the number of AV procedure has doubled. Mortality was significantly lower with all types of AV procedure despite very rapid aging of AVR patients. TAVI procedure rapidly grew in popularity. There is significant increase in the use of bioprosthesis.

Entities:  

Keywords:  Aortic valve replacement (AVR); bioprostheses; heart valve prosthesis; mechanical prosthesis; transcatheter aortic valve implantation (TAVI)

Year:  2019        PMID: 31372271      PMCID: PMC6626813          DOI: 10.21037/jtd.2019.06.04

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  30 in total

1.  Sutureless aortic valve replacement with the Trilogy Aortic Valve System: multicenter experience.

Authors:  Ingo Breitenbach; Gerhard Wimmer-Greinecker; Leo A Bockeria; Jerzy Sadowski; Christoph Schmitz; Boguslaw Kapelak; Krzysztof Bartus; Ravil Muratov; Wolfgang Harringer
Journal:  J Thorac Cardiovasc Surg       Date:  2010-08-02       Impact factor: 5.209

2.  The bicuspid aortic valve: adverse outcomes from infancy to old age.

Authors:  Mark B Lewin; Catherine M Otto
Journal:  Circulation       Date:  2005-02-22       Impact factor: 29.690

Review 3.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.

Authors:  Helmut Baumgartner; Judy Hung; Javier Bermejo; John B Chambers; Arturo Evangelista; Brian P Griffin; Bernard Iung; Catherine M Otto; Patricia A Pellikka; Miguel Quiñones
Journal:  Eur J Echocardiogr       Date:  2008-12-08

Review 4.  Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications.

Authors:  Thomas M Tadros; Michael D Klein; Oz M Shapira
Journal:  Circulation       Date:  2009-02-17       Impact factor: 29.690

5.  Mid-term pattern of survival, hemodynamic performance and rate of complications after medtronic freestyle versus homograft full aortic root replacement: results from a prospective randomized trial.

Authors:  Giovanni Melina; Fabio De Robertis; Jullien A R Gaer; Mohamed Amrani; Asghar Khaghani; Magdi H Yacoub
Journal:  J Heart Valve Dis       Date:  2004-11

6.  [POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].

Authors:  Marian Zembala; Krzysztof Wilczek; Roman Przybylski; Piotr Chodór; Paweł Nadziakiewicz; Marcin Krasoń; Jerzy Sadowski; Dariusz Dudek; Bogusław Kapelak; Danuta Forysz; Adam Witkowski; Marcin Demkow; Zbigniew Chmielak; Krzysztof Kuśmierski; Zbigniew Juraszyński; Andrzej Bochenek; Marek Cisowski; Maria Trusz-Gluza; Paweł Buszman; Stanisław Woś; Zbigniew Kalarus; Lech Poloński; Mariusz Gasior; Grzegorz Opolski; Witold Ruzyłło
Journal:  Kardiol Pol       Date:  2009-08       Impact factor: 3.108

7.  2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce W Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise
Journal:  Circulation       Date:  2008-09-26       Impact factor: 29.690

8.  Reoperation after fresh homograft replacement: 23 years' experience with 655 patients.

Authors:  Jerzy Sadowski; Boguslaw Kapelak; Krzysztof Bartus; Piotr Podolec; Pawel Rudzinski; Tomasz Myrdko; Karol Wierzbicki; Antoni Dziatkowiak
Journal:  Eur J Cardiothorac Surg       Date:  2003-06       Impact factor: 4.191

9.  Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database.

Authors:  James M Brown; Sean M O'Brien; Changfu Wu; Jo Ann H Sikora; Bartley P Griffith; James S Gammie
Journal:  J Thorac Cardiovasc Surg       Date:  2009-01       Impact factor: 5.209

Review 10.  Epidemiology and cardiovascular risk factors of aortic stenosis.

Authors:  Pompilio Faggiano; Francesco Antonini-Canterin; Ferdinando Baldessin; Roberto Lorusso; Antonio D'Aloia; Livio Dei Cas
Journal:  Cardiovasc Ultrasound       Date:  2006-07-01       Impact factor: 2.062

View more
  9 in total

1.  Decrease of surgical heart disease treatment during the COVID-19 pandemic (Cardiac Surgery COVID-19 Study - CSC 19 Study).

Authors:  Radoslaw Litwinowicz; Grzegorz Filip; Boguslaw Kapelak; Magdalena Bryndza; Kazimierz Widenka; Marek Deja; Piotr Suwalski; Mariusz Kowalewski; Krzysztof Bartus
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-06-29

2.  The use of cardiac valve procedures for rheumatic heart disease in Australia; a cross-sectional study 2002-2017.

Authors:  Pamela J Bradshaw; Hideo Tohira; James Marangou; Mark Newman; Bo Reményi; Vicki Wade; Christopher Reid; Judith M Katzenellenbogen
Journal:  Ann Med Surg (Lond)       Date:  2020-11-25

3.  Impact of pre-existing comorbidities on outcomes of patients undergoing surgical aortic valve replacement - rationale and design of the international IMPACT registry.

Authors:  Farhad Bakhtiary; Ali El-Sayed Ahmad; Rüdiger Autschbach; Peter Benedikt; Nikolaos Bonaros; Michael Borger; Oliver Dewald; Richard Feyrer; Hans-Joachim Geißler; Jürg Grünenfelder; Ka Yan Lam; Rainer Leyh; Andreas Liebold; Markus Czesla; Arash Mehdiani; Francesco Pollari; Saad Salamate; Justus Strauch; Andreas Vötsch; Alberto Weber; Daniel Wendt; Beate Botta; Peter Bramlage; Andreas Zierer
Journal:  J Cardiothorac Surg       Date:  2021-03-25       Impact factor: 1.637

4.  Bioprosthetic or mechanical heart valves: prosthesis choice for borderline patients?-Results from 9,616 cases recorded in Polish national cardiac surgery registry.

Authors:  Krzysztof Bartus; Radosław Litwinowicz; Jerzy Sadowski; Grzegorz Filip; Mariusz Kowalewski; Piotr Suwalski; Piotr Mazur; Anna Kędziora; Marek Jasiński; Marek Deja; Mariusz Kuśmierczyk; Pawel Czub; Michal Zembala; Marek Jemielity; Rafał Pawlaczyk; Zdzisław Tobota; Bohdan Maruszewski; Boguslaw Kapelak
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 3.005

5.  Early experience with the Thopaz+ chest drainage system - is this a new era in the management of post-cardiotomy bleeding?

Authors:  Karolina Pawelkowska; Stanislaw Bartus; Robert Sobczynski; Michal Medrzycki; Grzegorz Grudzien; Grzegorz Filip; Bartosz Cierpikowski; Krzysztof Bartus; Boguslaw Kapelak
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-01-09

6.  Changes in the Prosthesis Types Used for Aortic Valve Replacement after the Introduction of Sutureless and Rapid Deployment Valves in Korea: A Nationwide Population-Based Cohort Study.

Authors:  Hyeok Sang Woo; Ho Young Hwang; Ho Jin Kim; Joon Bum Kim; Sak Lee; Cheong Lim; Byung-Cheul Chang; Na Rae Lee; Youshin Suh; Jae Woong Choi
Journal:  J Chest Surg       Date:  2021-10-05

7.  Long-term survival following postoperative myocardial infraction after coronary artery bypass surgery.

Authors:  Radosław Litwinowicz; Piotr Mazur; Piotr Śliwiński; Magdalena Bryndza; Krzysztof Bartuś; Grzegorz Filip; Artur Bartoszcze; Jacek Piątek; Janusz Konstanty-Kalandyk; Mariusz Kowalewski; Krithika Ramaprabhu; Hubert Hymczak; Bogusław Kapelak; Anna Kędziora
Journal:  J Thorac Dis       Date:  2022-01       Impact factor: 3.005

Review 8.  Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective.

Authors:  Tiago R Velho; Rafael Maniés Pereira; Frederico Fernandes; Nuno Carvalho Guerra; Ricardo Ferreira; Ângelo Nobre
Journal:  Braz J Cardiovasc Surg       Date:  2022-05-02

9.  A summary of second systemic pulmonary shunt for congenital heart disease with pulmonary hypoxemia.

Authors:  Xue-Yong Yang; Xiao-Yong Jing; Zhe Chen; Lun Li; Xiang-Ming Fan; Jun-Wu Su
Journal:  J Cardiothorac Surg       Date:  2020-05-14       Impact factor: 1.637

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.